These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38040838)

  • 1. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models.
    Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS
    Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
    Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
    Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36.
    Paramasivam S; Perumal SS; Ekambaram SP
    Protein J; 2024 Apr; 43(2):243-258. PubMed ID: 38431537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.
    Turovskaya O; Foell D; Sinha P; Vogl T; Newlin R; Nayak J; Nguyen M; Olsson A; Nawroth PP; Bierhaus A; Varki N; Kronenberg M; Freeze HH; Srikrishna G
    Carcinogenesis; 2008 Oct; 29(10):2035-43. PubMed ID: 18689872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells.
    Wang L; Luo H; Chen X; Jiang Y; Huang Q
    PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A8/A9: From basic science to clinical application.
    Pruenster M; Vogl T; Roth J; Sperandio M
    Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
    Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
    Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.
    Chen B; Miller AL; Rebelatto M; Brewah Y; Rowe DC; Clarke L; Czapiga M; Rosenthal K; Imamichi T; Chen Y; Chang CS; Chowdhury PS; Naiman B; Wang Y; Yang D; Humbles AA; Herbst R; Sims GP
    PLoS One; 2015; 10(2):e0115828. PubMed ID: 25706559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of S100A8/A9-TLR4-NLRP3 Inflammasome Pathway in Contrast-Induced Acute Kidney Injury.
    Tan X; Zheng X; Huang Z; Lin J; Xie C; Lin Y
    Cell Physiol Biochem; 2017; 43(1):209-222. PubMed ID: 28854431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.
    Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D
    Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
    Nakajima Y; Inagaki Y; Kido J; Nagata T
    Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angelica oil restores the intestinal barrier function by suppressing S100A8/A9 signalling in mice with ulcerative colitis.
    Liu C; He YX; Zhang JN; Yang F; Wang SY; Hu JL; Yu Y
    Phytomedicine; 2023 Jan; 108():154490. PubMed ID: 36332386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
    Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
    Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
    Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
    Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
    Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue.
    Van Crombruggen K; Vogl T; Pérez-Novo C; Holtappels G; Bachert C
    Eur Respir J; 2016 Jan; 47(1):264-74. PubMed ID: 26493794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9.
    Möller A; Jauch-Speer SL; Gandhi S; Vogl T; Roth J; Fehler O
    Front Immunol; 2023; 14():1110185. PubMed ID: 37056775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.